Trial Profile
A phase 1 study investigating a nanocrystalline milled dispersion of AL (ALNCD) Aripiprazole Lauroxil for Schizophrenia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jul 2018
Price :
$35
*
At a glance
- Drugs Aripiprazole lauroxil (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- 29 Jul 2018 New trial record
- 13 Jul 2018 Results published in the Journal of Clinical Psychopharmacology